Olema Pharmaceuticals, Inc.

OLMA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.82-0.81%

2026-09-18

Financials

Valuation Metrics

Olema Pharmaceuticals, Inc.'s Market Cap is $858M. At end of 2025 it was $2.28B. Ranked #2542 of 3,121 in US market (top 81%), #1058 of 1,463 on NASDAQ (top 72%), #196 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 74%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$858M	US#2,542/3,121 Sec#196/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-205M	US—/3,121 Sec—/266
Total Assets	$487M	US#2,779/3,121 Sec#169/266
Net Assets	$431M	US#2,330/3,121 Sec#125/266
Value
P/B	1.99x	US#1,257/3,121 Sec#52/266
FCF Yield	-19.21%	US—/3,121 Sec—/266
Profitability
ROE	-47.51%	US#2,669/3,121 Sec#153/266
ROA	-42.04%	US#2,957/3,121 Sec#194/266
Financial Health
Debt Ratio	13.01%	US#148/3,121 Sec#62/266
Total Debt	$660000.00	US#2,996/3,121 Sec#250/266
FCF	$-165M	US#2,743/3,121 Sec#191/266
Cash	$49M	US#2,586/3,121 Sec#228/266
Current Ratio	8.86x	US#296/3,121 Sec#89/266
Performance
1Y Return	15.39%	US#968/3,121 Sec#142/266
1M Return	-13.17%	US#2,066/3,121 Sec#158/266
From 52W High	-72.92%	US#3,037/3,121 Sec#248/266
1Y MDD	-74.35%	US#3,010/3,121 Sec#245/266
Trading
Volume	2,508,984 shares	US#1,475/3,121 Sec#160/266
Trading Value	$25M	US#2,400/3,121 Sec#197/266
Per Share
EPS	$-2.34	US—/3,121 Sec—/266
BPS	$4.93	US#2,292/3,121 Sec#132/266